J Surg Ultrasound.  2023 Nov;10(2):25-31. 10.46268/jsu.2023.10.2.25.

Ultrasound Risk Stratification System of Thyroid Nodule

• Youn HJ
• Jeong HE
• Ahn HR
• Kang SY
• Jung SH

• KMID: 2553147
• DOI: http://doi.org/10.46268/jsu.2023.10.2.25

Abstract

Thyroid nodules are a common medical concern with an increasing prevalence due largely to the widespread use of ultrasonography (US). US is the primary diagnostic tool for identifying thyroid nodules, determining their size and characteristics, guiding fine-needle aspiration (FNA), and diagnosing lymph node metastasis. The most consistent US features indicating a malignancy in thyroid nodules include spiculated margins, microcalcifications, a taller-than-wide shape, and pronounced hypoechogenicity. Based on these imaging findings, clinicians must determine which nodules require further evaluation and which can be monitored over time. Despite the central role of thyroid US in managing these nodules, there is no clear consensus regarding which nodules should undergo US-guided FNA, nor is there a standardized terminology for describing the US features. Consequently, medical societies recommend using US risk stratification systems to standardize reporting and simplify clinical decision-making. This review aims to provide a comprehensive overview of the various US risk stratification systems employed for thyroid nodules, allowing readers to gain a better understanding of how nodules are assessed using these different systems. Furthermore, this study examines the efficacy, weaknesses, and potential pitfalls of these US risk stratification systems and discusses future perspectives for their optimal clinical application in managing thyroid nodules.

Keyword

Ultrasonography; Risk; Thyroid nodule

Reference

1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2016; 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Asso-ciation guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 26:1–133. DOI: 10.1089/thy.2015.0020. PMID: 26462967. PMCID: PMC4739132.

2. Ha EJ, Lim HK, Yoon JH, Baek JH, Do KH, Choi M, et al. 2018; ; Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology. Primary imaging test and appropriate biopsy methods for thyroid nodules: guidelines by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency. Korean J Radiol. 19:623–31. DOI: 10.3348/kjr.2018.19.4.623. PMID: 29962869. PMCID: PMC6005947.

3. Mandel SJ. 2004; Diagnostic use of ultrasonography in patients with nodular thyroid disease. Endocr Pract. 10:246–52. DOI: 10.4158/EP.10.3.246. PMID: 15310543.

4. Rago T, Vitti P. 2022; Risk stratification of thyroid nodules: from ultrasound features to TIRADS. Cancers (Basel). 14:717. DOI: 10.3390/cancers14030717. PMID: 35158985. PMCID: PMC8833686.

5. Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, et al. British Thyroid Association. 2014; British Thyroid Association. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 81 Suppl 1:1–122. DOI: 10.1111/cen.12515. PMID: 24989897.

6. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. 2016; AACE/ACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocri-nologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules--2016 update. Endocr Pract. 22:622–39. DOI: 10.4158/EP161208.GL. PMID: 27167915.

7. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. 2017; European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J. 6:225–37. DOI: 10.1159/000478927. PMID: 29167761. PMCID: PMC5652895.

8. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. 2017; ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 14:587–95. DOI: 10.1016/j.jacr.2017.01.046. PMID: 28372962.

9. Zhou J, Yin L, Wei X, Zhang S, Song Y, Luo B, et al. 2020; 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS. Endocrine. 70:256–79. DOI: 10.1007/s12020-020-02441-y. PMID: 32827126.

10. Ha EJ, Chung SR, Na DG, Ahn HS, Chung J, Lee JY, et al. 2021; 2021 Korean thyroid imaging reporting and data system and imaging-based management of thyroid nodules: Korean Society of Thyroid Radiology consensus statement and recommenda-tions. Korean J Radiol. 22:2094–123. DOI: 10.3348/kjr.2021.0713. PMID: 34719893. PMCID: PMC8628155.

11. Middleton WD, Teefey SA, Reading CC, Langer JE, Beland MD, Szabunio MM, et al. 2018; Comparison of performance characteristics of American College of Radiology TI-RADS, Korean Society of Thyroid Radiology TIRADS, and American Thyroid Association guidelines. AJR Am J Roentgenol. 210:1148–54. DOI: 10.2214/AJR.17.18822. PMID: 29629797.

12. Yoon SJ, Na DG, Gwon HY, Paik W, Kim WJ, Song JS, et al. 2019; Similarities and differences between thyroid imaging reporting and data systems. AJR Am J Roentgenol. 213:W76–84. DOI: 10.2214/AJR.18.20510. PMID: 30917027.

13. Na DG, Paik W, Cha J, Gwon HY, Kim SY, Yoo RE. 2021; Diagnostic performance of the modified Korean thyroid imaging reporting and data system for thyroid malignancy according to nodule size: a comparison with five society guidelines. Ultrasono-graphy. 40:474–85. DOI: 10.14366/usg.20148. PMID: 33472288. PMCID: PMC8446497.

14. Na DG. 2023; Clinical application of the 2021 Korean thyroid imaging reporting and data system (K-TIRADS). J Korean Soc Radiol. 84:92–109. DOI: 10.3348/jksr.2022.0158. PMID: 36818707. PMCID: PMC9935946.

15. Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, et al. 2009; An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 94:1748–51. DOI: 10.1210/jc.2008-1724. PMID: 19276237.

16. Tang AL, Falciglia M, Yang H, Mark JR, Steward DL. 2017; Validation of American Thyroid Association ultrasound risk assessment of thyroid nodules selected for ultrasound fine-needle aspiration. Thyroid. 27:1077–82. DOI: 10.1089/thy.2016.0555. PMID: 28657511.

17. Arambewela MH, Wijesinghe AM, Randhawa K, Bull M, Wadsley J, Balasubramanian SP. 2020; A pragmatic assessment of the British Thyroid Association "U classification" of thyroid nodules with a focus on their follow-up. Clin Radiol. 75:466–73. DOI: 10.1016/j.crad.2020.02.012. PMID: 32184000.

18. Negro R, Greco G, Colosimo E. 2017; Ultrasound risk categories for thyroid nodules and cytology results: a single institution's experience after the adoption of the 2016 update of medical guidelines by the American Association of Clinical Endocrino-logists and Associazione Medici Endocrinologi. J Thyroid Res. 2017:8135415. DOI: 10.1155/2017/8135415. PMID: 28744392. PMCID: PMC5506477.

19. Castellana M, Grani G, Radzina M, Guerra V, Giovanella L, Deandrea M, et al. 2020; Performance of EU-TIRADS in malignancy risk stratification of thyroid nodules: a meta-analysis. Eur J Endocrinol. 183:255–64. DOI: 10.1530/EJE-20-0204. PMID: 32544875.

20. Ha EJ, Moon WJ, Na DG, Lee YH, Choi N, Kim SJ, et al. 2016; A multicenter prospective validation study for the Korean thyroid imaging reporting and data system in patients with thyroid nodules. Korean J Radiol. 17:811–21. DOI: 10.3348/kjr.2016.17.5.811. PMID: 27587972. PMCID: PMC5007410.

21. Li W, Wang Y, Wen J, Zhang L, Sun Y. 2021; Diagnostic performance of American College of Radiology TI-RADS: a systematic review and meta-analysis. AJR Am J Roentgenol. 216:38–47. DOI: 10.2214/AJR.19.22691. PMID: 32603229.

22. Zhou J, Song Y, Zhan W, Wei X, Zhang S, Zhang R, et al. 2021; Thyroid imaging reporting and data system (TIRADS) for ultrasound features of nodules: multicentric retrospective study in China. Endocrine. 72:157–70. DOI: 10.1007/s12020-020-02442-x. PMID: 32852733.

23. Castellana M, Castellana C, Treglia G, Giorgino F, Giovanella L, Russ G, et al. 2020; Performance of five ultrasound risk stratification systems in selecting thyroid nodules for FNA. J Clin Endocrinol Metab. 105:dgz170. DOI: 10.1210/clinem/dgz170. PMID: 31690937.

24. Xu T, Wu Y, Wu RX, Zhang YZ, Gu JY, Ye XH, et al. 2019; Validation and comparison of three newly-released thyroid imaging reporting and data systems for cancer risk determination. Endocrine. 64:299–307. DOI: 10.1007/s12020-018-1817-8. PMID: 30474824.

25. Grani G, Lamartina L, Ascoli V, Bosco D, Biffoni M, Giacomelli L, et al. 2019; Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: toward the "right" TIRADS. J Clin Endocrinol Metab. 104:95–102. DOI: 10.1210/jc.2018-01674. PMID: 30299457.

26. Castellana M, Piccardo A, Virili C, Scappaticcio L, Grani G, Durante C, et al. 2020; Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma? Cancer Cytopathol. 128:250–9. DOI: 10.1002/cncy.22235. PMID: 31899594.

27. Castellana M, Virili C, Paone G, Scappaticcio L, Piccardo A, Giovanella L, et al. 2020; Ultrasound systems for risk stratification of thyroid nodules prompt inappropriate biopsy in autonomously functioning thyroid nodules. Clin Endocrinol (Oxf). 93:67–75. DOI: 10.1111/cen.14204. PMID: 32319108.

28. Russ G, Trimboli P, Buffet C. 2021; The new era of TIRADSs to stratify the risk of malignancy of thyroid nodules: strengths, weaknesses and pitfalls. Cancers (Basel). 13:4316. DOI: 10.3390/cancers13174316. PMID: 34503125. PMCID: PMC8430750.

29. Angell TE, Maurer R, Wang Z, Kim MI, Alexander CA, Barletta JA, et al. 2019; A cohort analysis of clinical and ultrasound variables predicting cancer risk in 20,001 consecutive thyroid nodules. J Clin Endocrinol Metab. 104:5665–72. DOI: 10.1210/jc.2019-00664. PMID: 31310316.